Please assess the completion status of the following clinical trial:

Trial Title: Combination Chemotherapy Followed by Radiation Therapy in Patients With Small Cell Lung Cancer

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: None
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: None
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
DISEASE CHARACTERISTICS:~* Microscopically proven small cell lung cancer~  * Diagnosis based on bronchial, mediastinal, pleural, lung, or lymph node biopsy, sputum cytology, or bronchial brushing or fine needle aspirate cytology~ * No pleural fluid cytology~* No prior therapy~PATIENT CHARACTERISTICS:~Age:~* Any age~Performance status:~* WHO 0-2~Hematopoietic:~* WBC more than 3,000~* ANC more than 1,500~* Platelets more than 100,000~Hepatic/Renal:~* Alkaline phosphatase, aminotransferase, sodium, and LDH normal or no more than 1 of them abnormal~* Creatinine or urea normal~* Creatinine clearance or GFR more than 65 mL/min~Other:~* No clinical evidence of infection~* No prior or concurrent malignancy that interferes with protocol treatments or comparisons~* No other condition that contraindicates treatment~* Willing and able to complete quality-of-life questionnaires~  * Hospital Anxiety and Depression Scale, Rotterdam Symptom Checklist, and EORTC questionnaires completed prior to randomization~PRIOR CONCURRENT THERAPY:~Biologic therapy:~* See Disease Characteristics~Chemotherapy:~* See Disease Characteristics~Endocrine therapy:~* See Disease Characteristics~Radiotherapy:~* See Disease Characteristics~Surgery:~* See Disease Characteristics

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).